NewsRoom Articles - Page 158 of 222

TuesdayJul 27, 2021 1:30 pm

Danish Researchers Discover That Medical Marijuana May Combat Essential Tremor

There is huge debate on what medicinal properties, if any, marijuana possesses, and researchers are working to uncover the effects of this substance. For example, a team of researchers from the University of Copenhagen in Denmark has discovered that medical marijuana has the ability to reduce involuntary shaking or essential tremor. Their research used a mouse model. The team’s work focused on a synthetic cannabinoid WIN55.212-2. The scientists found that when the mice were injected with this cannabinoid, astrocytes or support cells found within the brain and spinal cord of the mice were activated. When those support cells are activated,…

MondayJul 26, 2021 10:00 am

Post-Op Immunotherapy May Lower Risk of Bladder Cancer Recurrence

A new study conducted by researchers from the Memorial Sloan Kettering Cancer Center has discovered that after undergoing bladder removal operations, the risk of high-grade bladder cancer recurrence decreased after the nivolumab formulation was administered to patients. Together with a group of researchers, Dr. Dean Bajorin, who is a medical oncologist at the institute, evaluated more than 700 patients who had a high risk of urothelial cancer recurring after their kidney, ureter or bladder had been removed because of advanced metastatic bladder cancer. Urothelial cancers are tumors that develop in the muscle lining of the urinary system. These cancers are…

FridayJul 23, 2021 12:00 pm

Researchers Compare COVID-19 to Other Respiratory Ailments

A group of researchers from the United States and Israel conducted a study that compared the disease progression and presentation between in-hospital patients suffering from COVID-19 with other respiratory ailments such as influenza. They discovered that coronavirus patients displayed a unique cardiorespiratory, immune and metabolic profile, noting that the disease’s severity was higher in comparison with other respiratory illnesses. The virus that causes the coronavirus, SARS-CoV-2, is a deadly and highly infectious virus. It has infected more than 190 million individuals and claimed more than 4 million lives across the globe, despite the effective control measures that were implemented in…

ThursdayJul 22, 2021 12:17 pm

Study Finds That Focusing on the Past May Worsen Symptoms of Depression

A study recently published in the “Journal of Psychiatric Research” discovered that childhood trauma was linked to higher symptoms of depression, particularly in individuals who demonstrated a tendency to focus on the past instead of the future or even the present. Clinical depression, which is also known as major depressive disorder, is among the most common mental health conditions in the world. Childhood trauma is a typical feature of the disorder. The authors of the stud — Yingying Wang and colleagues — suggest that a personality factor may play a role in this association between depression and early trauma, noting…

ThursdayJul 22, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Preview Milestones for Novel Psychedelic Therapies in Investor Day Event

Tryp Therapeutics is a drug developer whose mission is to find novel solutions to conditions with otherwise unmet needs The company has distinguished itself by developing a synthetic oral psilocybin product that it aims to use in the treatment of chronic pain and eating disorder indications under its psychedelic medicine research program Tryp’s management team will address investors in a Fiscal Q3 review on July 29 that also serves as an opportunity to talk about upcoming milestones for the company Venture capital investment interest in psychedelic therapies has grown explosively from $1 million in 2017 to $329 million during the…

WednesdayJul 21, 2021 2:34 pm

Teasing About Weight Could Trigger Eating Disorders

Prior studies have discovered that young individuals who experience discrimination or teasing about their weight have higher rates of eating disorders, self-harm, depression and social isolation. However, these studies have primarily focused on high-income and white participants, which makes it unclear whether these findings apply to other groups as well. This is why researchers from the School of Public Health at the University of Minnesota in Minneapolis conducted a study to examine the link between eating disorders and weight stigma in a socioeconomically and racially/ethnically diverse sample of more than 1,500 young individuals in the United States. An eating disorder…

WednesdayJul 21, 2021 9:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS Pharmaceuticals also secures additional funding of $4.7 million for pivotal study and operations into Q2 2022, adding to company’s significant accomplishments in short time CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, achieved several fundamental clinical, corporate, and regulatory milestones over the…

TuesdayJul 20, 2021 2:36 pm

Adequate Levels of Vitamin D May Benefit Breast Cancer Patients

A new study has found that patients with breast cancer who have sufficient levels of vitamin D have better outcomes in the long term. Prof. Song Yao, who is the lead author of the study, suggests that maintaining adequate levels of vitamin D at the time of diagnosis and even after treatment may benefit breast cancer patients. The study’s results, which were presented at the American Society of Clinical Oncology’s virtual annual meeting, included findings that show that Black women had the lowest levels of vitamin D, which may explain why they had poorer outcomes after being diagnosed with breast…

TuesdayJul 20, 2021 9:30 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Former head of psychiatry products at FDA joins Cybin team. Laughren will help company plot its regulatory pathway as it studies and develops psychedelic medicines. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, is making strategic moves as it progresses with pre-clinical and clinical trials. One of those steps includes the company’s recent announcement that Thomas Laughren is joining Cybin’s clinical advisory board (https://ibn.fm/q0abz). A medical doctor who served as the director of the U.S. Food and Drug Administration’s division of psychiatry products for nearly three decades, Laughren will help the company plot its regulatory…

MondayJul 19, 2021 1:30 pm

Study Finds Regular Physical Activity Boosts Brain Health in Growing Children

A recent study conducted by researchers from Boston Children’s Hospital has found that exercise assists in the organization of developing brains in growing children. The study discovered that physical activity was linked to more flexible, strong and efficiently organized brain networks. Dr. Caterina Stamoulis, who is the study’s lead, conducted an analysis of brain imaging data collected from an estimated 6,000 children between the ages of nine and ten. Stamoulis, who is also the head of the Boston Children’s Computational Neuroscience Laboratory, explained that the physical activity children engaged in didn’t matter as long as they were active. She conducted…